Published in Cancer Weekly, July 31st, 2001
Y. Kinoshita and colleagues introduced and expressed murine GM-CSF and murine IL-6 genes in Renca cells, then subcutaneously injected Balb/c mice with either inactivated wild-type Renca, Renca-GM-CSF, Renca-IL-6, or a mixture of Renca-GM-CSF and Renca-IL-6. One to three weeks later, they challenged the mice with wild-type Renca cells.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.